Jesus Alvarez-Garcia

Dec 1, 2023 | onlinelibrary.wiley.com | Sonia Garcia |Jesus Alvarez-Garcia

Invited Editorial Sacubitril/valsartan: Where mechanism meets evidence-based medicine Sonia Rivas García, Sonia Rivas García Centro de Investigación en Red en Enfermedades Cardiovasculares (CIBERCV), Department of Cardiology, Ramón y Cajal University Hospital, Madrid, Spain Search for more papers by this authorJesús Álvarez-García, Corresponding Author Jesús Álvarez-García Centro de Investigación en Red en Enfermedades Cardiovasculares (CIBERCV), Department of Cardiology, Ramón y Cajal...

Aug 27, 2023 | cfrjournal.com | Harriette Van Spall |Holger Thiele |Jesus Alvarez-Garcia |Robert J. Mentz

ESC 23 - Late-Breaker host, Harriette Van Spall (McMaster University, CA) is joined by Holger Thiele (Heart Center Leipzig at University of Leipzig, DE) to discuss the findings from the ECLS-SHOCK Trial. The leading cause of death in hospitalised patients with acute myocardial infarction is cardiogenic shock.

Aug 27, 2023 | cfrjournal.com | Jesus Alvarez-Garcia |Robert J. Mentz |Joost Daemen

ESC 23 — Dr Jesus Alvarez-Garcia (Ramon and Cajal University Hospital, ES) considers the use of ReDS technology in patients with acute heart failure (ReDS-SAFE HF) (NCT04305717) in this short interview. The ReDS-SAFE HF study (Icahn School of Medicine at Mount Sinai) aimed to test the remote dielectric sensing (ReDS) system, a novel electromagnetic technology that can noninvasively quantify changes in lung fluid concentration.

May 23, 2023 | onlinelibrary.wiley.com | Jesus Alvarez-Garcia

Invited Editorial The opinions expressed in this article are not necessarily those of the Editors of the European Journal of Heart Failure or of the European Society of Cardiology. doi: 10.1002/ejhf.2864. No abstract is available for this article. References 1, , , , , , et al.; DAPA-HF Trial Committees and Investigators. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 2019; 381: 1995– 2008.